Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
Correa
P
P
van Doorn
L J
LJ
Bravo
J C
JC
Ruiz
B
B
Bravo
L E
LE
Realpe
J L
JL
D000658:Amoxicillin / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D018890:Chemoprevention; D003105:Colombia; D005500:Follow-Up Studies; D005757:Gastritis, Atrophic / Q000188:drug therapy / Q000382:microbiology*; D005838:Genotype; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000235:genetics* / Q000472:pathogenicity; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011230:Precancerous Conditions / Q000517:prevention & control; D012459:Salicylates / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000517:prevention & control; D017211:Treatment Failure; D014774:Virulence
D000863:Antacids; D000900:Anti-Bacterial Agents; D009942:Organometallic Compounds; D010406:Penicillins; D012459:Salicylates; D008795:Metronidazole; C015715:bismuth subsalicylate; D000658:Amoxicillin; D001729:Bismuth